एपीए उद्धरण

Howard, J. F., Bril, V., Burns, T. M., Mantegazza, R., Bilinska, M., Szczudlik, A., . . . Verschuuren, J. J. (2019). Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology.

शिकागो स्टाइल उद्धरण

Howard, James F., et al. "Randomized Phase 2 Study of FcRn Antagonist Efgartigimod in Generalized Myasthenia Gravis." Neurology 2019.

एमएलए उद्धरण

Howard, James F., et al. "Randomized Phase 2 Study of FcRn Antagonist Efgartigimod in Generalized Myasthenia Gravis." Neurology 2019.